New Immunotherapy Drugs May Be Big Advance in Lung Cancer Care

MONDAY, April 16, 2018 — Drugs designed to trigger a patient’s immune system may help boost survival for those battling lung cancer, two new studies found.
The first study found that when the immunotherapy drug Keytruda (pembrolizumab) was…
Source: Topamax